← Back to Search

Cognitive Behavioral Therapy for Sleep Disorders Due to Loss (RESTore Plus Trial)

N/A
Waitlist Available
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 18 months

Summary

This trial aims to help people who have recently lost a spouse or partner improve their sleep through a special type of therapy called Cognitive Behavior Therapy for Insomnia (CBT-I). Participants will have several online sessions with a trained therapist to learn better sleep habits. The study will compare this therapy to another group that only receives one informational session.

Who is the study for?
This trial is for adults who've lost a spouse or long-term partner within the last 3 months and are having sleep problems. They need internet access for online sessions and must score above a threshold on a sleep quality survey. Excluded are non-English speakers, pregnant/nursing women, those with certain medical conditions, long-term users of prescribed sleep meds, diagnosed with specific sleep disorders (except controlled OSA), drug users, and people on immunological medications.
What is being tested?
The study tests whether targeted Cognitive Behavior Therapy for Insomnia (CBT-I) can improve sleep among recently bereaved spouses compared to just getting information. Participants will either join six weekly online CBT-I sessions or attend one informational session and have their sleep monitored through watches and diaries at different stages.
What are the potential side effects?
Since this is a behavioral therapy trial focusing on insomnia after spousal loss rather than medication or invasive procedures, significant side effects aren't anticipated. However, discussing emotional topics during therapy could potentially cause temporary distress.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 18 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability
Adherence to the intervention
Attrition
+4 more
Secondary study objectives
Preliminary change in inflammation
Preliminary change in quality of life

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Targeted Intervention for Sleep and Bereavement (Targeted CBT-I)Experimental Treatment1 Intervention
This intervention consists of 6, 50-60-minute online individual sessions delivered via video conference. Content will include a CBT-I based program adapted to the specific needs of spousally bereaved individuals.
Group II: Information-Only ControlPlacebo Group1 Intervention
The information-only control consists of 1, 50-60-minute online individual session delivered via video conference. Content will provide basic psychoeducation about sleep and aging.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for improving Quality of Life (QoL) often involve behavioral interventions like Cognitive Behavioral Therapy for Insomnia (CBT-I). These treatments work by modifying thought patterns and behaviors that disrupt sleep, using techniques such as sleep hygiene education, cognitive restructuring, and relaxation exercises. By improving sleep quality, these interventions can reduce insomnia-related symptoms, which in turn can alleviate mood disturbances, fatigue, and impaired daily functioning. This is crucial for QoL patients as better sleep can lead to enhanced physical and mental health, thereby significantly improving their overall quality of life.

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,640 Previous Clinical Trials
957,532 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,810 Previous Clinical Trials
8,159,592 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,922 Previous Clinical Trials
47,760,706 Total Patients Enrolled

Media Library

Targeted Cognitive Behavior Therapy for Insomnia Clinical Trial Eligibility Overview. Trial Name: NCT05803499 — N/A
Spouses Research Study Groups: Targeted Intervention for Sleep and Bereavement (Targeted CBT-I), Information-Only Control
Spouses Clinical Trial 2023: Targeted Cognitive Behavior Therapy for Insomnia Highlights & Side Effects. Trial Name: NCT05803499 — N/A
Targeted Cognitive Behavior Therapy for Insomnia 2023 Treatment Timeline for Medical Study. Trial Name: NCT05803499 — N/A
~15 spots leftby Nov 2025